| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 3,260 | $220 | $701.1K |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 14,340 | $30 | $415.9K |
| J0178 | Injection, aflibercept, 1 mg | 390 | $700 | $271.4K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,430 | $90 | $124.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,430 | $60 | $88.8K |
| J2778 | Injection, ranibizumab, 0.1 mg | 400 | $180 | $73.2K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 2,260 | $30 | $60.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 740 | $70 | $54.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 260 | $110 | $28.3K |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 160 | $150 | $24.6K |